Evolent Health (EVH) PT Raised to $9.50 at Goldman Sachs
Tweet
Share
E-mailGet Alerts EVH Hot Sheet
Price: $29.09 -3.45%
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 10 | New: 14
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 10 | New: 14
Join SI Premium – FREE
Goldman Sachs analyst Robert Jones raised the price target on Evolent Health (NYSE: EVH) to $9.50 (from $8.50) while maintaining a Neutral rating.
You May Also Be Interested In
- Citi Starts Evolent Health (EVH) at Buy
- Goldman Sachs Downgrades Zhejiang Huayou Cobalt Co Ltd. (603799:CH) to Sell
- Winpak Ltd (WPK:CN) (WIPKF) PT Raised to Cdn$49 at CIBC
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
